DK0518767T3 - Analoger af amidderivater af bestemte methanobroforbundne quinoliziner - Google Patents
Analoger af amidderivater af bestemte methanobroforbundne quinolizinerInfo
- Publication number
- DK0518767T3 DK0518767T3 DK92401618T DK92401618T DK0518767T3 DK 0518767 T3 DK0518767 T3 DK 0518767T3 DK 92401618 T DK92401618 T DK 92401618T DK 92401618 T DK92401618 T DK 92401618T DK 0518767 T3 DK0518767 T3 DK 0518767T3
- Authority
- DK
- Denmark
- Prior art keywords
- chem
- treatment
- methanobro
- quinolizines
- analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP91401550A EP0517984A1 (en) | 1991-06-11 | 1991-06-11 | Derivatives of amide analogs of certain methano bridged quinolizines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0518767T3 true DK0518767T3 (da) | 2002-07-01 |
Family
ID=8208580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92401618T DK0518767T3 (da) | 1991-06-11 | 1992-06-11 | Analoger af amidderivater af bestemte methanobroforbundne quinoliziner |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP0517984A1 (da) |
| JP (1) | JP3377227B2 (da) |
| KR (1) | KR100234926B1 (da) |
| AT (1) | ATE214392T1 (da) |
| AU (1) | AU649836B2 (da) |
| CA (1) | CA2070573C (da) |
| DE (1) | DE69232473T2 (da) |
| DK (1) | DK0518767T3 (da) |
| ES (1) | ES2173863T3 (da) |
| FI (1) | FI112866B (da) |
| HU (1) | HU212735B (da) |
| IE (1) | IE921874A1 (da) |
| IL (1) | IL102132A (da) |
| NO (1) | NO305124B1 (da) |
| NZ (1) | NZ243031A (da) |
| PT (1) | PT518767E (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5508287A (en) * | 1992-02-24 | 1996-04-16 | Merrell Pharmaceuticals Inc. | 2,6-methano-2H-quinolizin derivative as 5-HT3 -receptor antagonist |
| EP0628043A1 (en) * | 1992-02-24 | 1994-12-14 | Merrell Pharmaceuticals Inc. | 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor antagonist |
| GB9214184D0 (en) * | 1992-07-03 | 1992-08-12 | Smithkline Beecham Plc | Pharmaceuticals |
| FR2765107B1 (fr) * | 1997-06-26 | 2000-03-24 | Sanofi Sa | Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil |
| KR20010032009A (ko) * | 1997-11-14 | 2001-04-16 | 에프.지.엠. 헤르만스 ; 이.에이치. 리링크 | 수면성 무호흡의 치료에 미타자핀을 사용하는 방법 |
| US7160898B2 (en) | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
| DK1066036T3 (da) | 1998-02-27 | 2006-08-21 | Univ Illinois | Midler med serotoninrelateret aktivitet til behandling af sövnapnö |
| CN1589269A (zh) | 2001-10-26 | 2005-03-02 | 康涅狄格大学 | 杂1,2－二氢化茚:一类新型有效的大麻配体 |
| JP2008524332A (ja) | 2004-12-20 | 2008-07-10 | コレジウム ファーマシューティカル， インク． | 睡眠傷害のための医薬組成物 |
| EP1968588A2 (en) | 2006-01-05 | 2008-09-17 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Crystalline forms of dolasetron base and processes for preparation thereof |
| CN101774971B (zh) * | 2010-02-10 | 2011-07-27 | 山东众诚药业股份有限公司 | 高纯度1-甲基吲唑-3-羧酸的生产方法 |
| GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB219363A (en) * | 1923-03-24 | 1924-07-24 | Abraham Preston | Improvements in or in connection with bed couches |
| DE3650772T2 (de) * | 1985-04-27 | 2003-04-03 | Hoffmann La Roche | Derivate von Indazole-3-carboxamide und -3-carboxylsäure |
| EP0330788A1 (en) * | 1988-03-01 | 1989-09-06 | Merrell Dow Pharmaceuticals Inc. | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia |
| GB8829079D0 (en) * | 1988-12-13 | 1989-01-25 | Beecham Group Plc | Novel compounds |
-
1991
- 1991-06-11 EP EP91401550A patent/EP0517984A1/en not_active Withdrawn
-
1992
- 1992-06-05 NZ NZ243031A patent/NZ243031A/en not_active IP Right Cessation
- 1992-06-05 CA CA002070573A patent/CA2070573C/en not_active Expired - Lifetime
- 1992-06-05 AU AU18037/92A patent/AU649836B2/en not_active Expired
- 1992-06-08 IL IL10213292A patent/IL102132A/en not_active IP Right Cessation
- 1992-06-10 NO NO922270A patent/NO305124B1/no not_active IP Right Cessation
- 1992-06-10 FI FI922695A patent/FI112866B/fi not_active IP Right Cessation
- 1992-06-10 KR KR1019920010016A patent/KR100234926B1/ko not_active IP Right Cessation
- 1992-06-10 HU HU9201939A patent/HU212735B/hu unknown
- 1992-06-11 DK DK92401618T patent/DK0518767T3/da active
- 1992-06-11 ES ES92401618T patent/ES2173863T3/es not_active Expired - Lifetime
- 1992-06-11 DE DE69232473T patent/DE69232473T2/de not_active Expired - Lifetime
- 1992-06-11 JP JP17598392A patent/JP3377227B2/ja not_active Expired - Lifetime
- 1992-06-11 AT AT92401618T patent/ATE214392T1/de active
- 1992-06-11 PT PT92401618T patent/PT518767E/pt unknown
- 1992-06-11 EP EP92401618A patent/EP0518767B1/en not_active Expired - Lifetime
- 1992-07-01 IE IE187492A patent/IE921874A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP3377227B2 (ja) | 2003-02-17 |
| DE69232473D1 (de) | 2002-04-18 |
| KR100234926B1 (ko) | 1999-12-15 |
| PT518767E (pt) | 2002-09-30 |
| FI922695A (fi) | 1992-12-12 |
| AU1803792A (en) | 1992-12-24 |
| EP0518767B1 (en) | 2002-03-13 |
| JPH05202044A (ja) | 1993-08-10 |
| NO305124B1 (no) | 1999-04-06 |
| ES2173863T3 (es) | 2002-11-01 |
| HU212735B (en) | 1996-10-28 |
| CA2070573C (en) | 2003-04-15 |
| NO922270D0 (no) | 1992-06-10 |
| EP0518767A3 (en) | 1993-05-05 |
| AU649836B2 (en) | 1994-06-02 |
| HU9201939D0 (en) | 1992-08-28 |
| FI112866B (fi) | 2004-01-30 |
| IL102132A (en) | 1996-10-31 |
| EP0518767A2 (en) | 1992-12-16 |
| FI922695A0 (fi) | 1992-06-10 |
| KR930000518A (ko) | 1993-01-15 |
| EP0517984A1 (en) | 1992-12-16 |
| IL102132A0 (en) | 1993-01-14 |
| NO922270L (no) | 1992-12-14 |
| ATE214392T1 (de) | 2002-03-15 |
| IE921874A1 (en) | 1992-12-16 |
| HUT61549A (en) | 1993-01-28 |
| DE69232473T2 (de) | 2002-11-21 |
| CA2070573A1 (en) | 1992-12-12 |
| NZ243031A (en) | 1994-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0518767T3 (da) | Analoger af amidderivater af bestemte methanobroforbundne quinoliziner | |
| FI941378A0 (fi) | Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus | |
| ATE143806T1 (de) | Verbesserungen von oder in bezug auf exzitatorische aminosäurenrezeptorantagonisten | |
| NZ238956A (en) | 3-arylindole or 3-arylindazole derivatives and medicaments thereof. | |
| DK0565377T3 (da) | Terapeutiske midler til behandling af Parkinsons sygdom | |
| SG47949A1 (en) | 2-Heterocyclicethylamine derivatives and their use as pharmaceuticals | |
| DK1068184T3 (da) | N-aryloxyethylaminderivater til behandling af despression | |
| ES2111326T3 (es) | Derivados de imidazolona y oxazolona como antagonistas de dopamina. | |
| ATE132136T1 (de) | Antitumor anthracenderivate | |
| ATE108444T1 (de) | 3-isoxazolonderivate, ihre herstellung und ihre anwendung in der therapeutik. |